Natasha Giordano, Dipexium Pharmaceuticals, Inc.'s CEO and a director of the company, just received 86,872 options from the company. The strike price of the options received was $6.72, and these expire on August 11, 2027. Giordano now owns at least 86,872 options on the company.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: Loss per share Basic... - Nov. 9, 2017
Departure of Directors or Certain - Oct. 27, 2017